Literature DB >> 33764556

Phosphoproteomics reveals a distinctive Mec1/ATR signaling response upon DNA end hyper-resection.

Ethan J Sanford1, William J Comstock1, Vitor M Faça1,2, Stephanie C Vega1, Robert Gnügge3, Lorraine S Symington3, Marcus B Smolka1.   

Abstract

The Mec1/ATR kinase is crucial for genome maintenance in response to a range of genotoxic insults, but it remains unclear how it promotes context-dependent signaling and DNA repair. Using phosphoproteomic analyses, we uncovered a distinctive Mec1/ATR signaling response triggered by extensive nucleolytic processing (resection) of DNA ends. Budding yeast cells lacking Rad9, a checkpoint adaptor and an inhibitor of resection, exhibit a selective increase in Mec1-dependent phosphorylation of proteins associated with single-strand DNA (ssDNA) transactions, including the ssDNA-binding protein Rfa2, the translocase/ubiquitin ligase Uls1, and the Sgs1-Top3-Rmi1 (STR) complex that regulates homologous recombination (HR). Extensive Mec1-dependent phosphorylation of the STR complex, mostly on the Sgs1 helicase subunit, promotes an interaction between STR and the DNA repair scaffolding protein Dpb11. Fusion of Sgs1 to phosphopeptide-binding domains of Dpb11 strongly impairs HR-mediated repair, supporting a model whereby Mec1 signaling regulates STR upon hyper-resection to influence recombination outcomes. Overall, the identification of a distinct Mec1 signaling response triggered by hyper-resection highlights the multi-faceted action of this kinase in the coordination of checkpoint signaling and HR-mediated DNA repair.
© 2021 The Authors.

Entities:  

Keywords:  Dpb11; Mec1; Sgs1; homologous recombination; resection

Mesh:

Substances:

Year:  2021        PMID: 33764556      PMCID: PMC8126923          DOI: 10.15252/embj.2020104566

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  89 in total

Review 1.  Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis.

Authors:  Mary Ellen Moynahan; Maria Jasin
Journal:  Nat Rev Mol Cell Biol       Date:  2010-03       Impact factor: 94.444

2.  Mec1/Tel1-dependent phosphorylation of Slx4 stimulates Rad1-Rad10-dependent cleavage of non-homologous DNA tails.

Authors:  Geraldine W-L Toh; Neal Sugawara; Junchao Dong; Rachel Toth; Sang Eun Lee; James E Haber; John Rouse
Journal:  DNA Repair (Amst)       Date:  2010-04-10

3.  Heteroduplex rejection during single-strand annealing requires Sgs1 helicase and mismatch repair proteins Msh2 and Msh6 but not Pms1.

Authors:  Neal Sugawara; Tamara Goldfarb; Barbara Studamire; Eric Alani; James E Haber
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-15       Impact factor: 11.205

4.  The DNA replication and damage checkpoint pathways induce transcription by inhibition of the Crt1 repressor.

Authors:  M Huang; Z Zhou; S J Elledge
Journal:  Cell       Date:  1998-09-04       Impact factor: 41.582

5.  Regulation of Rad51 function by phosphorylation.

Authors:  Sonja Flott; Youngho Kwon; Ying Zhang Pigli; Phoebe A Rice; Patrick Sung; Stephen P Jackson
Journal:  EMBO Rep       Date:  2011-07-08       Impact factor: 8.807

6.  Phosphoproteomics reveals a distinctive Mec1/ATR signaling response upon DNA end hyper-resection.

Authors:  Ethan J Sanford; William J Comstock; Vitor M Faça; Stephanie C Vega; Robert Gnügge; Lorraine S Symington; Marcus B Smolka
Journal:  EMBO J       Date:  2021-03-25       Impact factor: 11.598

7.  The Swi2-Snf2-like protein Uls1 is involved in replication stress response.

Authors:  Magdalena Cal-Bakowska; Ireneusz Litwin; Tomasz Bocer; Robert Wysocki; Dorota Dziadkowiec
Journal:  Nucleic Acids Res       Date:  2011-07-15       Impact factor: 16.971

8.  Separable roles for Mec1/ATR in genome maintenance, DNA replication, and checkpoint signaling.

Authors:  Michael Charles Lanz; Susannah Oberly; Ethan James Sanford; Sushma Sharma; Andrei Chabes; Marcus Bustamante Smolka
Journal:  Genes Dev       Date:  2018-06-13       Impact factor: 11.361

9.  Dna2 is a structure-specific nuclease, with affinity for 5'-flap intermediates.

Authors:  Jason A Stewart; Judith L Campbell; Robert A Bambara
Journal:  Nucleic Acids Res       Date:  2009-11-24       Impact factor: 16.971

10.  Maximized quantitative phosphoproteomics allows high confidence dissection of the DNA damage signaling network.

Authors:  Vitor Marcel Faca; Ethan J Sanford; Jennifer Tieu; William Comstock; Shagun Gupta; Shannon Marshall; Haiyuan Yu; Marcus B Smolka
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

View more
  5 in total

1.  Fe-NTA Microcolumn Purification of Phosphopeptides from Immunoprecipitation (IP) Eluates for Mass Spectrometry Analysis.

Authors:  Ethan J Sanford; Marcus B Smolka
Journal:  Bio Protoc       Date:  2021-08-05

2.  Phosphoproteomics reveals a distinctive Mec1/ATR signaling response upon DNA end hyper-resection.

Authors:  Ethan J Sanford; William J Comstock; Vitor M Faça; Stephanie C Vega; Robert Gnügge; Lorraine S Symington; Marcus B Smolka
Journal:  EMBO J       Date:  2021-03-25       Impact factor: 11.598

Review 3.  DNA damage checkpoint and repair: From the budding yeast Saccharomyces cerevisiae to the pathogenic fungus Candida albicans.

Authors:  Shuangyan Yao; Yuting Feng; Yan Zhang; Jinrong Feng
Journal:  Comput Struct Biotechnol J       Date:  2021-11-25       Impact factor: 7.271

Review 4.  Saccharomyces cerevisiae as a Model System for Eukaryotic Cell Biology, from Cell Cycle Control to DNA Damage Response.

Authors:  Laura Vanderwaeren; Rüveyda Dok; Karin Voordeckers; Sandra Nuyts; Kevin J Verstrepen
Journal:  Int J Mol Sci       Date:  2022-10-01       Impact factor: 6.208

5.  A regulatory phosphorylation site on Mec1 controls chromatin occupancy of RNA polymerases during replication stress.

Authors:  Verena Hurst; Kiran Challa; Felix Jonas; Romain Forey; Ragna Sack; Jan Seebacher; Christoph D Schmid; Naama Barkai; Kenji Shimada; Susan M Gasser; Jérôme Poli
Journal:  EMBO J       Date:  2021-09-27       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.